Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Larger Is The Superdisintegrants Market Expected To Become By 2029 Compared With Its 2025 Level?
The superdisintegrants market has observed substantial growth over recent years. It is projected to expand from $1.09 billion in 2024 to $1.16 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.2%. The expansion seen during the historic period stems from factors including the increasing prevalence of chronic and lifestyle-related diseases, the development within the global pharmaceutical industry, a rising demand for orally disintegrating tablets (ODTs), the growth in geriatric and pediatric populations, and an enhanced focus on improving drug bioavailability.
The superdisintegrants market size is expected to show robust growth over the next few years. It is projected to expand to $1.47 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.1%. The expansion in this forecast period can be attributed to factors such as the rising demand for oral solid dosage forms, the increasing prevalence of chronic diseases, and the broadening scope of pharmaceutical manufacturing. Major trends anticipated during this time include technological integration within manufacturing processes, advancements in co-processed excipients leading to a shift toward natural and biodegradable superdisintegrants, the development of novel drug-delivery systems, and increased collaboration between excipient and pharmaceutical companies.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21292&type=smp
Which Major Market Drivers Are Shaping The Future Of The Superdisintegrants Market?
The anticipated expansion of the superdisintegrants market is expected to be propelled by the growing output of generic drugs. A generic drug is a medication that possesses identical active ingredients, dosage, strength, route of administration, quality, and performance to a brand-name drug but is typically available at a reduced cost. This rise in generic drug manufacturing is fueled by the increasing consumer demand for affordable medications, the expiration of patents on branded drugs, and governmental initiatives aimed at lowering healthcare expenses. Superdisintegrants, when included in generic drugs, enhance tablet disintegration and dissolution, thereby ensuring quicker drug release, improved bioavailability, and better patient adherence. For instance, in January 2023, a report from the Food and Drug Administration, a US-based government department, estimated that 91% of prescriptions in the United States in 2022 were filled with generic drugs, with over 32,000 generic medications having been approved by the Food and Drug Administration to date. Therefore, the increasing generic drug production is a primary driver for the growth of the superdisintegrants market.
What Are The Segment Types Shaping The Superdisintegrants Market?
The superdisintegrantsmarket covered in this report is segmented –
1) By Type: Natural Superdisintegrants; Synthetic Superdisintegrants; Other Superdisintegrants
2) By Formulation: Tablets; Capsules
3) By Therapeutic Area: Gastrointestinal Diseases; Neurological Diseases; Oncology; Infectious Diseases; Cardiovascular Diseases; Hematological Diseases
Subsegments:
1) By Natural Superdisintegrants: Starch; Cellulose; Chitosan; Gums; Other Natural Superdisintegrants
2) By Synthetic Superdisintegrants: Cross-linked Polyvinylpyrrolidone (Crospovidone); Sodium Starch Glycolate; Croscarmellose Sodium; Other Synthetic Superdisintegrants
3) By Other Superdisintegrants: Ion Exchange Resins; Surfactant-Based Superdisintegrants; Other Specialized Superdisintegrants
How Are Emerging Market Trends Shaping The Superdisintegrants Industry Landscape?
Leading companies within the superdisintegrants market are concentrating on innovative products, such as multifunctional disintegrants, to enhance drug formulation efficiency, improve tablet disintegration speed, and optimize patient compliance in pharmaceutical applications. A multifunctional disintegrant is an advanced excipient that integrates disintegration, binding, and flow-enhancing properties, thereby improving tablet formulation efficiency and drug release. For instance, in June 2023, Ashland Inc., a US-based chemicals company, introduced Polyplasdone Plus, a co-processed multifunctional direct compression superdisintegrant engineered to enhance tablet disintegration, powder flow, and lubrication during pharmaceutical manufacturing. This innovation simplifies production by eliminating two manufacturing steps, improving tablet hardness, and supporting high-speed and continuous manufacturing processes.
Which Industry Leaders Are Driving Innovation Across The Superdisintegrants Market?
Major companies operating in the superdisintegrants market are BASF SE, Merck KGaA, DuPont de Nemours Inc., IFF Pharma Solutions, Ingredion Incorporated, Roquette Freres SA., FMC Corporation, Azelis Group, Ashland Inc., Piramal Healthcare, Colorcon Inc. Ltd., Boai NKY Pharmaceuticals Ltd., JRS Pharma, Faran Shimi Pharmaceutical, DFE Pharma India Private Limited., Sigachi Industries Limited, Corel Pharma Chem, Maple Biotech Pvt. Ltd., Shanghai Chineway Pharmaceutical Technology Co. Ltd., JH Nanhang Life Sciences Co. Ltd.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/superdisintegrants-global-market-report
Which Regional Markets Are Contributing Most To The Superdisintegrants Industry Expansion?
North America was the largest region in the superdisintegrants market in 2024. The regions covered in the superdisintegrants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Superdisintegrants Market Report:
https://www.thebusinessresearchcompany.com/customise?id=21292&type=smp
Browse Through More Reports Similar to the Global Superdisintegrants Market 2025, By The Business Research Company
Pharmaceutical Api Manufacturing Global Market Report 2025
Generic Pharmaceuticals Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report
Pharmaceutical Sterility Testings Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model